Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/29/2008 First Published: 12/8/2006


1.		Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV, Phase III				Treatment				Active				21 and under				Other				GPOH-NB2004 EU-20661, NCT00410631


2.		German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL01 NCT00198991


3.		Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL03 NCT00199004


4.		Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Over 15				Other				GMALL05 NCT00199082


5.		German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL04 NCT00199017

Last Modified: 12/5/2007 First Published: 4/1/1999


6.		Phase III Randomized Study of Dexamethasone Versus Prednisolone During Induction Therapy and Prolonged Versus Conventional Duration Asparaginase During Consolidation and Late Intensification Therapy in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 18				Other				EORTC-58951 NCT00003728


7.		ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Age-Adjusted IPI of 1

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 59				Other				LNH03-2B NCT00140595

Last Modified: 7/25/2008 First Published: 1/25/2007


8.		Phase III Randomized Study of Risk-Adjusted Therapies in Pediatric Patients With Acute Lymphoblastic Leukemia (All Randomized Treatment Arms Closed to Accrual as of 6/30/2006)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				1 to 18				Other				ALL-BFM-2000 EU-20682, NCT00430118

First Published: 9/29/2008


9.		Phase III Randomized Study of Risk-Adjusted Management in Pediatric Patients With Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and under				Other				MOTOL-ALL-IC-BFM-2002 ALL-IC-BFM-2002, EU-20871, NCT00764907


10.		A Study of Two Associations of Rituximab and Chemotherapy, With a PET–Driven Strategy, in Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 59				Other				2007.462 NCT00498043

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute